A214150 logo

CLASSYS Inc. Stock Price

KOSDAQ:A214150 Community·₩2.9t Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

A214150 Share Price Performance

₩0
-58600.00 (-100.00%)
₩65,000.00
Fair Value
₩0
-58600.00 (-100.00%)
Price ₩0

A214150 Community Narratives

·
Fair Value ₩65k 32.7% undervalued intrinsic discount

Why Calling Classys Korea's #2 Aesthetic Player Is a Massive Mispricing

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

A214150 logo

Why Calling Classys Korea's #2 Aesthetic Player Is a Massive Mispricing

Fair Value: ₩65k 32.7% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record with high growth potential.

0 Risks
4 Rewards

CLASSYS Inc. Key Details

₩346.9b

Revenue

₩82.1b

Cost of Revenue

₩264.8b

Gross Profit

₩129.1b

Other Expenses

₩135.7b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.08k
76.34%
39.13%
26.5%
View Full Analysis

About A214150

Founded
2007
Employees
394
CEO
Yoon Jun-oh
WebsiteView website
classys.co.kr

CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that delivers micro-level laser beams fractionally to the tissue; Secret DUO, a multi-functional device that delivers high-frequency energy through needle electrodes; and Fortra, a 4 wavelengths diode laser. It also provides SCIZER and CLATUU Alpha for non-invasive subcutaneous fat reduction; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE, a combination of four handpieces used for acne suction, muscle pain relief, and other pain relief; FORSHAPE, an RF treatment system used to increase metabolism, blood circulation, and tissue recovery; and INTRASURE for lifting, wrinkle reduction, body contouring, and cellulite reduction. In addition, the company offers AQUAPURE II, which exfoliates hyper-keratinized dead skin cells; Reepot, a medical device that delivers energy to tissue; veloce, which enhances treatment results; Pento, a laser surgical device for tissue incision, destruction, and removal; and curas hybrid laser system. Further, it sells cosmetics. The company offers its products under the Classys, Cluederm, and Skederm brands. It serves distributors, clinics, hospitals, and direct end users. The company was founded in 2007 and is headquartered in Seoul, South Korea. CLASSYS Inc. is a subsidiary of BCPE Centur Investments, LP.

Recent A214150 News & Updates

New Narrative Jul 20

Why Calling Classys Korea's #2 Aesthetic Player Is a Massive Mispricing

1. The Razor-and-Blade Engine: Elite ~50% OPM Cash Generation Classys’ true moat is not one-off hardware capital sales (Shurink, Volnewmer).

Recent updates

No updates

CLASSYS Inc. Competitors